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in the kidney in humans and rats repetitively exposed to hemeHeme protein-induced chronic renal inflammation: Suppressive
proteins. Such up-regulation represents an anti-inflammatoryeffect of induced heme oxygenase-1.
response since the genetic deficiency of HO-1 markedly in-Background. Heme oxygenase (HO) is the rate-limiting en-
creases activation of NF-kB, MCP-1 expression, and tubuloin-zyme in the degradation of heme; its inducible isozyme, HO-1,
protects against acute heme protein-induced nephrotoxicity terstitial cellular inflammation.
and other forms of acute tissue injury. This study examines
the induction of HO-1 in the kidney chronically inflamed by
heme proteins and the functional significance of such an induc-
Heme oxygenase (HO) is the rate-limiting enzyme intion of HO-1.
Methods. Studies were undertaken in a patient with chronic the degradation of heme, facilitating the conversion of
tubulointerstitial disease in the setting of paroxysmal nocturnal heme to biliverdin, in the course of which iron is released
hemoglobinuria (PNH), in a rat model of chronic tubulointer- and carbon monoxide is emitted [1–3]. Its isozyme, HO-1,stitial nephropathy caused by repetitive exposure to heme pro-
is induced by diverse stressors [1–3], and in some instances,teins, and in genetically engineered mice deficient in HO-1
(HO-1 2/2) in which hemoglobin was repetitively adminis- such induction of HO-1 confers cytoprotection against
tered. acute toxicity [1–3]. For example, induction of HO-1
Results. The kidney in PNH evinces robust induction of HO-1 protects against acute cytotoxicity induced by heme pro-in renal tubules in the setting of chronic inflammation. The heme
teins [4–6], hypoxia [7], hyperoxia [8], sepsis [9], acuteprotein-enriched urine from this patient, but not urine from a
healthy control subject, induced expression of HO-1 in renal nephrotoxicity from chemotherapeutic agents [10], and
tubular epithelial cells (LLC-PK1 cells). A similar induction ischemia-reperfusion injury in the transplanted organ [11].
of HO-1 and related findings are recapitulated in a rat model of In addition to the recognition that HO-1 can guardchronic inflammation induced by repetitive exposure to heme
against acute cytotoxicity, there is growing evidence thatproteins. Additionally, in the rat, the administration of heme
HO-1 down-regulates the inflammatory response [2, 3,proteins induces monocyte chemoattractant protein (MCP-1).
The functional significance of HO-1 so induced was uncovered 12]. For example, acute cellular inflammation following
in the HO-1 knockout mouse: Repeated administration of he- pleurisy in a rat model is significantly ameliorated by
moglobin to HO-1 1/1 and HO-1 2/2 mice led to intense
the up-regulation of HO-1 [13], while in a model ofinterstitial cellular inflammation in HO-1 2/2 mice accompa-
cardiac xenotransplant rejection, the deficiency of HO-1nied by striking up-regulation of MCP-1 and activation of one
of its stimulators, nuclear factor-kB (NF-kB). These findings exacerbates xenotransplantation-related cell injury and
were not observed in similarly treated HO-1 1/1 mice or in inflammatory responses [14]. Chronic vascular inflam-
vehicle-treated HO-1 2/2 and HO-1 1/1 mice.
mation associated with vascular rejection in antibody-Conclusion. We conclude that up-regulation of HO-1 occurs
induced transplant arteriosclerosis is also ameliorated by
up-regulation of HO-1 [15]. The mechanisms by which
1 See Editorial by Kanwar, p. 378. HO-1 influences the inflammatory response is one of
intense interest [2, 3, 12]. Understanding the basis forKey words: tubulointerstitial inflammation, nuclear factor-kB, mono-
cyte chemoattractant protein-1, paroxysmal nocturnal hemoglobinuria. such anti-inflammatory effects would be widely applica-
ble to a number of disease states, including assorted
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and systemic microbial infections, and the systemic in- logic alterations and deposition of iron, respectively. Ad-
ditional sections of the kidney biopsy were studied byflammatory response syndrome.
Our laboratory has demonstrated the functional sig- immunoperoxidase, as previously described [28, 29], for
the expression of HO-1 and ferritin (vide infra).nificance of induced HO-1 in protecting the kidney
against the acute cytotoxic effects of heme proteins, as The capacity of hemoglobin-enriched urine from this
patient to induce HO-1 in renal proximal tubular epithe-occurs in settings in which the kidney is exposed to myo-
globin and hemoglobin [4, 6]. Such studies focus on acute lial cells was examined in LLC-PK1 cells. LLC-PK1 cells
were grown to confluence, as previously described [30].heme protein-induced nephrotoxicity that occurs in dis-
eases such as rhabdomyolysis and intravascular hemoly- Samples of urine from the patient and a healthy control
subject were diluted 1/5 with Hank’s balanced salt solu-sis [16]. Heme proteins may also contribute to a chronic
inflammatory response in the kidney. For example, tion (HBSS), titrated to pH 7.4, and then filtered through
a 0.2 micron filter. Confluent monolayers were then ex-chronic inflammation appears in the kidney continually
exposed to heme proteins as occurs in hematuric nephrit- posed to HBSS alone, urine from the healthy subject
diluted with HBSS (1/5), or urine from the patient dilutedides [17], sickle cell disease [18, 19], and recurrent hemo-
lytic episodes [16]. Whether HO-1 is up-regulated in such with HBSS (1/5). Following incubation for four hours,
the respective media were removed, the cell monolayerschronic, heme protein-induced, renal inflammation and
influences the nature and severity of the inflammatory were washed, and all cell monolayers were incubated for
an additional two hours in Dulbecco’s modified Eagle’sresponse is an issue that, to date, has not been addressed.
Using a multilayered approach that incorporates find- medium (DMEM). In additional studies, cells were incu-
bated in the presence of urine from the patient dilutedings in human disease and in relevant models in rats and
mice, this study examined the induction of HO-1 in the with HBSS 1/5, 1/10, and 1/25; cells were also incubated
in the presence or absence of pyruvate (5 mmol/L), akidney chronically inflamed by heme proteins. We then
explored the functional significance of such an induction scavenger for hydrogen peroxide [31]. In these and sub-
sequent studies, RNA was extracted using the Trizolof HO-1. This line of investigation was initially stimu-
lated by a patient who developed progressive renal insuf- method (GIBCO BRL, Gaithersburg, MD, USA), as pre-
viously described [30]. Ten micrograms of total RNA fromficiency in the setting of paroxysmal nocturnal hemoglo-
binuria (PNH); the relevant findings in this patient thus each sample were separated on an agarose gel and trans-
ferred to a nylon membrane. Membranes were hybrid-provide the provenance for subsequent explorations in
relevant disease models. PNH is characterized by recur- ized overnight with a 32P-labeled human HO-1 cDNA
probe. Autoradiograms were standardized, as previouslyrent episodes of hemolysis, which intermittently exposes
the kidney to heme proteins [20–22]. We demonstrate described [30], by factoring the optical density of the
message for HO-1 with the optical density of the 18Sthat in this condition, the kidney evinces robust induction
of HO-1 in the presence of smoldering renal inflamma- rRNA, the latter obtained on a negative of the ethidium
bromide-stained nylon membrane.tion. Similar induction of HO-1 and related findings in
the kidney in PNH are recapitulated in a rat model of
Studies in ratschronic inflammation induced by repetitive exposure to
heme proteins. This latter model in the rat suggested a The glycerol model was employed in the study of heme
protein-induced renal injury in the rat. Hypertonic glyc-mechanism based on the expression of the chemokine
monocyte chemoattractant protein-1 (MCP-1)—a mono- erol (50%, 7.5 mL/kg body wt) was injected intramuscu-
larly in rats dehydrated overnight and was repeated atcyte chemoattractant protein that contributes to chronic
renal inflammation in diverse states [23–27]—by which weekly intervals, as previously described [32]. After the
fourth injection, the kidneys were fixed in formalin, andHO-1 may modulate the inflammatory response. To ex-
plore this mechanism further, as well as the significance immunoperoxidase studies for the detection of HO-1 and
ferritin were performed [28, 29]. Staining for HO-1 wasof induced HO-1, we examined renal alterations in genet-
ically engineered mice deficient in HO-1 that were repet- carried out using a polyclonal rat antibody (SPA-895;
Stressgen, Victoria, British Columbia, Canada) as theitively exposed to heme proteins.
primary antibody, a horseradish peroxidase-conjugated
secondary antibody (SAB-300; Stressgen) and diamino-
METHODS
benzidine as substrate for localization; kidney sections
Clinical case report were also stained for ferritin using an anti-rat ferritin
antibody, as previously described [4, 29]. Kidney sectionsA renal biopsy was obtained from an adult patient
with a history of PNH who developed chronic renal insuf- were stained for the assessment of the deposition of iron
using Prussian blue.ficiency. The kidney biopsy specimen was immersion fixed
in formalin, and sections were stained with hematoxylin In additional studies, the effect of rat hemoglobin on
gene expression in the kidney was examined. Rats wereand eosin and with Prussian blue for assessment of histo-
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dehydrated overnight and then given rat hemoglobin (60 tion of 100 mL of Nonidet-P40, the sample was centri-
fuged at 13,000 3 g for five minutes at 48C; the resultantmg/100 g body wt) or saline vehicle intravenously. The
kidneys were harvested, and RNA from kidneys was pellet was resuspended in 60 mL of a buffer consisting
of 50 mmol/L HEPES, 10% glycerol, 300 mmol/L NaCl,extracted using the Trizol method; total RNA from each
sample was separated on an agarose gel and transferred 50 mmol/L KCl, and protease inhibitors. Following cen-
trifugation at 13,000 3 g for 10 minutes, the supernatantto a nylon membrane. Membranes were hybridized over-
night with a 32P-labeled mouse HO-1 or MCP-1 cDNA was harvested and used in the EMSA. The oligonucleo-
tide employed corresponded to the two NF-kB bindingprobe. Autoradiograms were standardized as described
previously in this article. sequences present within the enhancer of the HIV LTR
(59-ACAAGGGACTTTCCGCTGGGGACTTTCCA
Studies in mice GGGA-39), labeled with [32P] gATP, as described by
Paya et al [35, 36]. Ten micrograms of protein extractHemoglobin or vehicle was administered on a weekly
basis to HO-1 1/1 and HO-1 2/2 mice. Homozygous were incubated with 4 mL of binding buffer (5 mmol/L
MgCl2, 50 mmol/L Tris-HCl, pH 7.5, 250 mmol/L NaCl,HO-1 null mutants were generated by targeted disrup-
tion of the HO-1 gene as described by Poss and Tone- 20% glycerol, 2.5 mmol/L EDTA, 2.5 mmol/L DTT, 0.25
mg/mL poly dI.dC) and 2 mL of 32P-labeled NF-kB probe.gawa [33]. Colonies of mice were maintained by breeding
HO-1 2/2 males with HO-1 1/2 females. Offspring Termination was effected after 30 minutes with 2 mL of
gel-loading buffer (250 mmol/L Tris-HCl, pH 7.5, 0.2%were genotyped at the time of weaning by using polymer-
ase chain reaction to amplify the wild-type and mutant bromophenol blue, 40% glycerol). The binding reaction
was analyzed by electrophoresis in a nondenaturing 7%alleles of genomic DNA obtained from tail samples.
HO-1 1/1 mice (wild-type) were used as controls. polyacrylamide gel and visualized by autoradiography.
Groups of HO-1 1/1 and HO-1 2/2 mice comprised
Statisticssimilar numbers of male and female mice. Prior to the
initiation of chronic intermittent administration of hemo- Results are expressed as means 6 SEM and are consid-
ered statistically significant for P , 0.05. For comparisonglobin, the body weights of the HO-1 2/2 mice (mean,
22.7 6 1.6 g; range, 18.3 to 29.2 g) were matched to HO-1 between unpaired groups, the Student’s t-test or the
Mann–Whitney test was employed as appropriate.1/1 mice (mean, 22.9 6 1.4; range, 17.7 to 27.2 g); the
mean age of the HO-1 2/2 mice was 13 6 1 weeks
(range, 11 to 16 weeks), while the mean age of the HO-1
RESULTS
1/1 mice was 10 6 1 weeks (range, 8 to 14 weeks).
Clinical case description: Renal expression of HO-1At weekly intervals, mice were administered mouse
following recurrent exposure to heme proteins inhemoglobin (90 mg/100 g body weight; Sigma, St. Louis,
paroxysmal nocturnal hemoglobinuriaMO, USA) via a tail vein injection; prior to the adminis-
tration of hemoglobin, HO-1 1/1 and HO-1 2/2 mice The patient presented with aplastic anemia at age 22
years and, subsequently, exhibited a positive Ham’s test.were deprived of water for 16 hours but were allowed
free access to rodent chow. Plasma creatinine concentra- He was treated intermittently with prednisone and aspi-
rin, and for most of his clinical course, he experiencedtions were determined on tail vein blood samples using a
Beckman Creatinine Analyzer II (Beckman Instruments, hemoglobinuria. Seventeen years after his initial presen-
tation, the patient developed an upper respiratory tractInc., Fullerton, CA, USA) [4]. Seven days after the last
injection of hemoglobin, the kidneys were harvested for infection and was treated with amoxicillin/clavulanic
acid; one week later, he presented with arthritis, facialhistologic examination with hematoxylin and eosin and
Northern analyses for the expression of MCP-1 mRNA. edema, and urticaria; the serum creatinine was elevated
at 2.1 mg/dL. Serum sickness was diagnosed, and highIn these kidneys, the electrophoretic mobility shift
assay (EMSA) was performed to assess activation of doses of corticosteroids were commenced. Although the
arthritis and edema rapidly improved, the renal insuffi-nuclear factor-kB (NF-kB). A modified version of the
method described by Rangan et al was used to prepare ciency did not, and renal function declined in subsequent
years. A kidney biopsy showed chronic tubulointerstitialnuclear protein extracts from the kidney and to perform
the EMSA [34]. Half of a mouse kidney was homoge- disease and tubular deposition of iron (Fig. 1A), along
with marked tubular staining for the major iron-bindingnized in 400 mL of an ice-cold buffer, the latter consti-
tuted by 10 mmol/L HEPES (pH 7.9), 10 mmol/L KCl, protein, ferritin (Fig. 1B). The glomeruli appeared nor-
mal. The heme-degrading enzyme, HO-1, was markedly2 mmol/L MgCl2, 0.1 mmol/L ethylenediaminetetraacetic
acid (EDTA), and assorted protease inhibitors [0.5 mmol/L induced in renal tubules (Fig. 1C). The normal human
kidney does not express HO-1 by immunoperoxidasedithiothreitol (DTT), 1 mmol/L phenylmethylsulfonyl
fluoride (PMSF), 0.05 mg/mL leupeptin, 0.1 mg/mL aprot- staining in renal tubules, nor does it evince such expres-
sion of ferritin, or deposits of iron (data not shown).inin, and 0.01 mg/mL pepstatin A]. Following the addi-
Fig. 1. (A) Prussian blue staining of the kid-
ney biopsy demonstrating chronic tubuloin-
terstitial disease with extensive tubular depos-
its of iron (original magnification 3105). (B)
Immunoperoxidase staining of the kidney
biopsy demonstrating expression of ferritin in
renal tubules (original magnification 3105).
(C) Immunoperoxidase staining of the kidney
biopsy demonstrating expression of HO-1 in
renal tubules (original magnification 3105).
(D) Northern analysis for HO-1 expression in
renal tubular epithelial cells (LLC-PK1) ex-
posed to control medium, urine from a healthy
subject diluted in control medium (1/5), and
urine from the patient diluted in control me-
dium (1/5). Each lane represents RNA ex-
tracted from an individual plate.
Fig. 6. Histologic sections of the kidney in
mice subjected to weekly intravenous admin-
istration of mouse hemoglobin (90 mg/100 g
body weight) and harvested seven days after
the eighth injection and stained with hematox-
ylin and eosin (original magnification 3200).
(A) Kidney histology in HO-1 1/1 mice. (B)
Kidney histology in HO-1 2/2 mice.
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Fig. 2. Heme oxygenase-1 (HO-1) mRNA expression in renal tubular epithelial cells (LLC-PK1) exposed to urine from the patient with paroxysmal
nocturnal hemoglobinuria (PNH) diluted 1/5, 1/10, 1/25, and urine from the patient diluted 1/5 and in the presence of pyruvate (Pyr; 5 mmol/L).
Each lane represents RNA extracted from a single plate. The individual standardized densitometric readings are provided below the Northern
analyses.
To determine whether hemoglobin-enriched urine may tial inflammation in the setting of up-regulation of inter-
stitial collagens [32]. To determine whether up-regulationprovide a mechanism accounting for the induction of
HO-1, we exposed renal proximal tubular epithelial cells, of HO-1 occurs in this model—and thereby to under-
score its similarity to findings observed in PNH—weLLC-PK1 cells, to urine from this patient and similarly
examined the expression of HO-1 in the kidneys of ratsdiluted urine from a healthy subject. LLC-PK1 cells in
subjected to weekly intramuscular injections of glycerol.culture readily expressed HO-1 mRNA when exposed
In such kidneys, we demonstrate that the renal tubules into urine from this patient but not to urine from a healthy
rats, as in the patient exposed to heme proteins, exhibitedsubject or to control medium (Fig. 1D).
marked up-regulation of HO-1 by immunoperoxidaseSuch induction of HO-1 in LLC-PK1 cells exposed to
(Fig. 3A). These kidneys also displayed increased stain-urine from the patient was dose dependent, since the
ing for ferritin (Fig. 3B) and marked deposition of ironexpression of HO-1 mRNA was less with increased dilu-
in renal tubules and in the interstitial macrophages (Fig.tion of the urine (Fig. 2). The induction of HO-1 mRNA
3C). Thus, this recently described rat model of chronicin LLC-PK1 cells by urine from the patient with PNH
tubulointerstitial disease recapitulates the characteristicswas not affected by the incubation of urine with pyruvate
described in the patient with PNH, namely, up-regulation(5 mmol/L), the latter representing an effective scaven-
of HO-1 in tubules, increased ferritin expression, andger of hydrogen peroxide in urine. Hydrogen peroxide
increased deposition of iron in the tubulointerstitium.may be present in urine in concentrations up to 150
In this rat model of chronic tubulointerstitial inflam-mmol/L, and such concentrations of hydrogen peroxide
mation, MCP-1, a potent chemoattractant for leukocytes,can induce HO-1 [31]. The inability of pyruvate to atten-
is incriminated in the tubulointerstitial inflammation thatuate the expression of HO-1 indicates that hydrogen
ensues [32]. In the present studies, we considered theperoxide per se is unlikely to serve as the stimulus for
possibility that expression of MCP-1 may be regulatedthe induction of HO-1.
by HO-1, a hypothesis based on the following grounds:Chronic renal insufficiency in this patient progressed
Since MCP-1 is an oxidant-inducible gene [37], whereasto end-stage disease, which was treated initially by hemo-
induction of HO-1 represents an antioxidant responsedialysis and subsequently by transplantation. The post-
[1–3], then the induction of an antioxidant gene such astransplant course was complicated by acute rejection and
HO-1 may render cellular redox less disposed to the up-cytomegalovirus infections. Biopsy of the renal trans-
regulation of an oxidant-inducible gene such as MCP-1.plant showed pronounced staining of renal tubules for
To address this possibility, we first determined whetherHO-1 and ferritin (data not shown); tubular staining for
heme proteins per se induce MCP-1. Since induction ofHO-1 is not seen in healthy, adequately functioning renal
MCP-1 in the kidney in the glycerol-induced model ofallografts in patients without PNH (data not shown).
heme protein-instigated renal injury in the rat may sim-
Studies in rats: Expression of heme oxygenase-1 in the ply represent a nonspecific manifestation of a chronically
rat kidney following recurrent exposure to inflamed kidney—and one driven by mechanisms other
heme proteins than heme proteins—we first examined the direct effect
of heme proteins on kidney expression of MCP-1.We have recently described the occurrence of tubulo-
interstitial disease in rats induced by repetitive exposure As demonstrated in Figure 4, the administration of a
heme protein, hemoglobin, to rats led to marked up-to heme proteins. Rats subjected weekly to glycerol-
induced myolysis and hemolysis exhibited tubulointersti- regulation of MCP-1. Such an induction of MCP-1 was
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Fig. 3. (A) Expression of HO-1 by immuno-
peroxidase staining in control (left panel) and
glycerol-treated rats (right panel; original
magnification 3400). (B) Expression of ferri-
tin by immunoperoxidase staining in control
(left panel) and glycerol-treated rats (right
panel; original magnification 3400). (C) Iron
staining by prussian blue in control (left panel)
and glycerol-treated rats (right panel; original
magnification 3400).
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Fig. 4. Expression of HO-1 and MCP-1 mRNA in the kidney in rats
subjected to rat hemoglobin (60 mg/100 g body wt) or saline vehicle
administered intravenously six hours previously. Each lane represents
RNA extracted from a single kidney from an individual rat. Fig. 5. Plasma creatinine concentrations in HO-1 1/1 (h) and HO-1
2/2 (j) mice one day after weekly intravenous administration of mouse
hemoglobin (90 mg/100 g body wt).
accompanied by the expected induction of HO-1 mRNA.
This induction of MCP-1 is notable for the following
absence of HO-1 in HO-1 2/2 mice led to a greaterreasons: First, it identifies a novel stimulus for this che-
elevation in plasma creatinine after the first dose of he-mokine, namely, heme proteins such as hemoglobin; sec-
moglobin in the HO-1 2/2 mice, and this greater eleva-ond, such early expression in the kidney of MCP-1 occurs
tion in plasma creatinine again persisted after the secondin the absence of tubulointerstitial inflammation. Thus,
dose (Fig. 5). However, from the third dose onward,heme proteins, such as hemoglobin, can directly up-regu-
there was a failure of plasma creatinine to rise in eitherlate the chemokine MCP-1 in the kidney.
group after the injection of hemoglobin. Thus, resistance
Studies in mice: Renal responses following repetitive to acute decline in kidney function eventually occurs in
exposure to heme proteins in HO-1 1/1 and HO-1 2/2 mice and appears independent of HO-1 in
HO-1 2/2 mice this setting (Fig. 5). However, at the end of the study
when renal histology was examined, the HO-1–deficientTo determine whether expression of HO-1 influences
mice demonstrated markedly worse histologic injury,tubulointerstitial disease and MCP-1 expression induced
whereas such injury was relatively mild in HO-1 1/1by heme proteins, we utilized genetically engineered
mice following repetitive exposure to heme proteinsmice that are deficient in HO-1 and in which heme pro-
(Fig. 6, vide infra). At the end of the study, the meanteins were administered at weekly intervals. We use this
plasma creatinine in HO-1 2/2 mice subjected to weeklyapproach rather than a pharmacologic approach based
injections of hemoglobin was not significantly differenton chronic administration of competitive inhibitors of
from the mean plasma creatinine in similarly treatedHO in the glycerol model of heme protein-mediated
HO-1 1/1 mice (0.20 6 0.04 vs. 0.22 6 0.04 mg/dL, P 5injury for several reasons. First, there are concerns re-
NS). There were no significant differences in plasmagarding the capacity of these inhibitors to influence other
creatinine in HO-1 1/1 and HO-1 2/2 mice prior tosystems besides HO [38–40]. Second, as a model of repet-
the administration of saline vehicle, and in neither groupitive exposure to heme protein in mice, we used hemoglo-
was there any significant acute alteration in plasma creat-bin rather than repeated intramuscular administration
inine in response to saline, or at the end of the studyof glycerol because hemoglobin can be dosed precisely,
when kidneys were harvested (data not shown).and its use avoids the vagaries associated with variable
Figure 6 shows the marked interstitial cellular in-amounts of myolysis and hemolysis that occur in the
flammation in conjunction with interstitial fibrosis, tubu-glycerol model. These latter considerations are especially
lar atrophy and dilation, in the kidneys of HO-1 2/2 micegermane given the much smaller anterior thigh muscle
subjected to repetitive administration of heme proteinsmass in the mouse.
(Fig. 6B). Such features were scant in similarly treatedMouse hemoglobin was thus administered weekly to
HO-1 1/1 mice (Fig. 6A). In neither group was thereHO-1 1/1 mice and HO-1 2/2 mice. Renal function,
evidence of glomerular injury. The histology of the kid-as reflected by plasma creatinine, was sequentially fol-
neys in HO-1 1/1 and HO-1 2/2 mice, harvested afterlowed, and after eight weekly injections, histologic exam-
eight infusions of saline vehicle administered at weeklyination of the kidney was performed. During the course
intervals, appeared normal (data not shown). Thus, theof these studies, three out of seven HO-1 2/2 mice died
with no deaths occurring in the HO-1 1/1 mice. The absence of HO-1 predisposes toward increased mortality
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Fig. 7. Expression of MCP-1 mRNA in the kidney in HO-1 1/1 mice
and HO-1 2/2 mice subjected to weekly intravenous administration
of mouse hemoglobin (90 mg/100 g body weight) or saline vehicle.
Northern analyses for MCP-1 expression were performed using RNA
extracted from kidneys harvested seven days after the eighth injection
of hemoglobin. Each lane represents RNA extracted from a single
kidney from an individual mouse.
and marked tubulointerstitial inflammation with repeti-
tive doses of hemoglobin.
To determine the mechanism accounting for such
marked leukocytic infiltration, we considered the possi-
bility that the chemokine MCP-1, a chemoattractant for
monocytes and T cells, would be up-regulated. Northern
analyses conducted in these kidneys demonstrated marked
up-regulation of MCP-1 mRNA in HO-1 2/2 mice sub-
jected to repetitive injections of hemoglobin, whereas
there was scant, if any, expression of MCP-1 in HO-1
Fig. 8. Electrophoretic mobility shift assay (EMSA) for NF-kB in the2/2 mice subjected to repeated injections of vehicle and
kidney in HO-1 2/2 mice and HO-1 1/1 mice subjected to weeklyin HO-1 1/1 mice subjected to repeated injections of intravenous administration of mouse hemoglobin (90 mg/100 g body
hemoglobin or vehicle (Fig. 7). Thus, worsened tubulo- weight) or saline vehicle; EMSA were performed using nuclear extracts
from kidneys harvested seven days after the eighth injection of hemo-interstitial inflammation occurring in HO-1 2/2 mice,
globin.repetitively injected with hemoglobin, was accompanied
by fulminant up-regulation of MCP-1.
To examine further the mechanism accounting for
such up-regulation of MCP-1 in HO-1 2/2 mice repeti- disease, also arise in circumstances in which the kidney
tively injected with hemoglobin, we considered whether is repetitively exposed to heme proteins, occurring, for
activation of NF-kB—a transcription factor that regulates example, in hematuric glomerulopathies [17], in sickle
expression of MCP-1 [41–43]—was involved. As demon- cell nephropathy [18, 19], and in PNH [20].
strated in the EMSA (Fig. 8), activation of NF-kB was Paroxysmal nocturnal hemoglobinuria is a membrane
markedly more pronounced in the HO-1 2/2 mice sub- disorder of the erythrocyte arising from an underlying
jected to repetitive injections of hemoglobin as compared abnormality in the glycosylphosphatidylinositol anchor
with any of the other groups. Thus, activation of NF-kB in the cytoskeleton of the erythrocyte [20–22]. This latter
and accompanying up-regulation of MCP-1 are accentu- abnormality leads to the loss of several membrane pro-
ated in HO-1 2/2 mice subjected to repetitive injections teins that, in turn, predisposes the erythrocyte toward
of hemoglobin as compared with vehicle-injected HO-1 lysis. Such hemolysis exposes the kidney, continually, to
2/2 mice or HO-1 1/1 mice subjected to vehicle or heme proteins, and in a certain subset of these patients,
hemoglobin.
chronic tubulointerstitial inflammation and progressive
renal disease occur [20, 21]. We demonstrate that the
DISCUSSION kidney in PNH exhibits marked iron overload and large
amounts of ferritin, the major iron-binding protein.Acute and chronic nephropathies occur in settings in
Along with such changes, HO-1 is markedly up-regulatedwhich the kidney is exposed to heme proteins. For exam-
in the renal tubules, the renal compartment that is contin-ple, acute pigment nephropathy can be induced by rhab-
ually exposed to heme proteins. That heme proteins maydomyolysis and intravascular hemolysis [16], and in these
contribute to the induction of HO-1 is indicated by thediseases, heme proteins, myoglobin, or hemoglobin, of-
robust induction of HO-1 in renal epithelial cells exposedten in conjunction with volume depletion or sepsis, con-
to heme protein-enriched urine from the described pa-tribute to acute renal damage [16]. Chronic nephropa-
thies, characterized in part by chronic tubulointerstitial tient, but not from heme protein-free urine from healthy
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controls. It would be of interest to determine the extent HO-1 influences the triphasic response to heme proteins.
The greater rise in plasma creatinine in HO-1 2/2 mice,to which HO-1 and ferritin are induced in the kidney in
patients with renal diseases other than PNH. Also of as compared to the HO-1 1/1 mice, after the first and
second doses of hemoglobin, attests to the importanceinterest is the extent to which HO-1 and ferritin can be
induced in LLC-PK1 cells by urine from patients with of HO-1 in protecting against acute sensitivity to heme
proteins. However, by the time of the third injection,renal diseases other than PNH and by urine enriched
with proteins other than hemoglobin. HO-1 2/2 mice did not evince a rise in plasma creatinine
following the administration of hemoglobin. Thus, it ap-We have recently described a rat model of chronic
tubulointerstitial inflammation that is induced by recur- pears that unlike its involvement in attenuating the acute,
early, sensitivity to heme proteins, HO-1 may not berent exposure to heme proteins [32]. This model exhibits
histologic features that resemble the kidney in PNH, required in the acquisition of renal resistance that ap-
pears by the third injection of hemoglobin, at least asexhibiting as it does, interstitial inflammation in conjunc-
tion with chronic up-regulation of interstitial and base- reflected by the rise in plasma creatinine. However, the
third phase, which is characterized by chronic inflamma-ment membrane collagens [32]. We now provide further
evidence in support of the similarity of renal features of tion, is clearly one that is influenced by HO-1. The ab-
sence of HO-1 leads to striking exacerbation of intersti-this rat model and the clinical disease: In the rat kidney,
large deposits of iron are present in conjunction with tial inflammation and tubulointerstitial disease. These
findings demonstrate that within the kidney, a chronicprominent up-regulation of ferritin, and notably, HO-1
is markedly up-regulated in renal tubules. inflammatory response is influenced by HO-1. Specifi-
cally, the absence of HO-1 transforms what is otherwiseTo analyze the functional effect of induced HO-1, we
examined the influence of HO-1 on each aspect of the a mild lesion into an aggressive interstitial cellular infil-
tration. From these findings, we suggest that the induc-renal response to repetitive exposure to heme proteins.
As recently characterized, the renal response to repeti- tion of HO-1 in chronic interstitial disease may serve as
a governor that limits the chronic inflammatory cellulartive exposure to heme proteins in the rat revealed a
triphasic pattern consisting of initial sensitivity to the response that would otherwise occur.
To explore a potential mechanism whereby the defi-acute toxicity of heme proteins, acquired resistance to
these effects of heme proteins when repetitively adminis- ciency of HO-1 promotes interstitial cellular infiltration
in the kidney, we focused on MCP-1. This chemokine,tered, and eventually, a progressive inflammatory response
[32]. Acute sensitivity represents the acute functional a potent chemoattractant for monocytes and T cells, is
incriminated in the initiation and perpetuation of chronicand structural deterioration that occurs in response to
the first insult. Acquired renal resistance to injury is tubulointerstitial inflammation in assorted nephritides
[23–27]. An additional consideration motivating the exam-reflected by the blunted fall in glomerular filtration rate
that is accompanied by reduced amounts of necrosis and ination of MCP-1 arose from our recent description of
a model of repetitive administration of heme proteins inapoptosis in renal tubular epithelial cells with each suc-
cessive insult, and chronic inflammation is characterized the rat wherein MCP-1, an oxidant-inducible chemokine
[37], was up-regulated [32]. Based on such findings, weby progressive tubulointerstitial inflammation in con-
junction with up-regulation of MCP-1. suggested that MCP-1 may contribute to the attendant
chronic tubulointerstitial inflammation in this model [32].In the present study, we examined the functional sig-
nificance of expression of HO-1 in the kidney repetitively In the present studies, we provide the novel finding
that heme proteins, such as hemoglobin, directly induceexposed to heme proteins. To this end, we utilized geneti-
cally engineered mice that are deficient in HO-1 and MCP-1. When examined seven days after the last dose
of hemoglobin, fulminant induction of MCP-1 in thein which heme proteins were administered at weekly
intervals. We used this knockout model rather than a kidney occurred in HO-1 2/2 mice subjected to re-
peated exposure to hemoglobin, but not in HO-1 1/1pharmacologic approach based on repeated administra-
tion of competitive inhibitors of HO over an extended mice subjected to hemoglobin or vehicle, or in HO-1
2/2 mice subjected to saline vehicle. Thus, the markedperiod, since there are concerns regarding the nonspe-
cific actions of these pharmacologic inhibitors of HO-1. exacerbation of interstitial inflammation in the absence
of HO-1 is attended by intense up-regulation of a potentAs a model of repetitive exposure to heme protein in
mice, we used mouse hemoglobin rather than repeated chemoattractant for monocytes and T lymphocytes,
namely, MCP-1.administration of glycerol: Hemoglobin can be dosed
precisely, and its use avoids the vagaries associated with The lack of expression of MCP-1 in the kidney in
HO-1 1/1 mice in these studies (Fig. 7) merits comment.variable amounts of muscle and red cell lysis that occur
in the glycerol model. These studies in mice were undertaken seven days after
the administration of hemoglobin, whereas the study ofThe repetitive administration of hemoglobin to HO-1
2/2 mice allowed the examination of the extent to which MCP-1 expression in rats was undertaken six hours after
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the administration of hemoglobin (Fig. 4). The intense of renal inflammation, HO-1 may subserve a functional
role. Studies along these lines examining the effect ofup-regulation of MCP-1 observed six hours after a given
dose of hemoglobin in rodents with inducible HO-1 thus induced HO-1 on the inflammatory response in such
states would be of interest.subsides by seven days. The lack of expression of MCP-1
in the kidney in HO-1 1/1 mice when studied seven Our studies demonstrating that hemoglobin, directly
administered, induces MCP-1, offer a mechanism account-days after hemoglobin likely represents the abatement in
expression of previously up-regulated MCP-1. As such, it ing for progressive tubulointerstitial injury in assorted
hematuric glomerulonephritides [17]. In such conditions,underscores the persistence in, and intensity of, expres-
sion of MCP-1 in the HO-1–deficient state following a renal tubules are exposed to a burden of hemoglobin as
red blood cells are engulfed and degraded within thesimilar exposure to hemoglobin.
Among the factors that regulate MCP-1 is NF-kB. tubular epithelial cells [55]. Moreover, the direct micro-
injection of red blood cells into rat proximal tubulesActivation of NF-kB occurs in renal inflammation and
is achieved, in some instances, by alterations in cellular eventually incurs an inflammatory response [56]. We
speculate that such inflammatory responses in the tubu-redox [25, 34, 41, 42]. We thus examined activation of
NF-kB in HO-1 1/1 and HO-1 2/2 mice subjected to lointerstitium may reflect the induction of MCP-1 by
hemoglobin. It would be of interest to determine thehemoglobin or vehicle. As demonstrated, the activation
of NF-kB mirrored the pattern of expression found for renal expression of MCP-1 in chronic hematuric condi-
tions and hemoglobinuric states (PNH, prosthetic heartMCP-1: Activation of NF-kB was much more prominent
in HO-1 2/2 mice subjected to hemoglobin as compared valves, etc.). Perhaps the extent to which MCP-1 is ex-
pressed in these states—and thus the propensity to chronicwith HO-1 1/1 mice exposed to hemoglobin or vehicle
or HO-1 2/2 mice subjected to vehicle. We speculate tubulointerstitial disease—is inversely influenced by the
extent to which HO-1 is induced. This latter relationshipthat the deficiency of HO-1 promotes activation of
NF-kB, which, in turn, induces such cytokines as MCP-1. may underlie the lack of progressive renal injury in states
of low grade hemoglobinuria, as occurs in patients withThat the deficiency of HO-1 promotes chronic cellular
prosthetic heart valves.inflammation through up-regulation of NF-kB and MCP-1
In summary, we demonstrate the induction of HO-1adds to the mechanistic underpinnings whereby HO-1
in the kidney in PNH. We suggest that such inductiondown-regulates inflammation. Products of HO such as
represents an adaptive response that enables the degra-carbon monoxide may suppress proinflammatory cyto-
dation of heme, an oxidant abundant in tissues in PNH.kines such as platelet-derived growth factor and endo-
This induction of HO-1 and other germane features isthelin-1 [44]. Other products such as bilirubin can attenu-
faithfully reproduced in the setting of chronic tubuloin-ate adhesion of leukocytes to the venular endothelium
terstitial disease in the rat kidney following repetitive[45] or inhibit the activation of NADPH oxidase [46].
exposure to heme proteins. The importance of such anHO-1 reduces the up-regulation of intercellular adhesion
induction of HO-1 in down-regulating the inflammatorymolecule-1 that otherwise occurs in endothelial cells in
response is uncovered by the fulminant interstitial in-response to heme [47]. The striking up-regulation of
flammation, striking up-regulation of the chemokineMCP-1 in the absence of HO-1 provides another mecha-
MCP-1, and activation of the transcription factor NF-kBnism by which HO-1 may act as an anti-inflammatory
occurring in HO-1–deficient mice repetitively exposedagent. By suppressing MCP-1, a major chemoattractant
to heme proteins. We conclude by speculating that up-for monocytes and T cells, HO-1 may thus deprive these
regulation of HO-1 in the injured kidney may assist incells of a potent stimulus that recruits them into an in-
down-regulating cellular infiltration by suppressing NF-jured area.
kB–driven activation of MCP-1.Besides its induction in toxic models of renal injury
[1–3], induction of HO-1 is increasingly described in
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